Heart rhythm fix may also repair leaky valve: scientists build prediction model

NCT ID NCT07096219

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at people with persistent atrial fibrillation (an irregular heartbeat) and moderate-to-severe functional mitral regurgitation (a leaky heart valve). Researchers want to see if a procedure called catheter ablation—which zaps abnormal heart tissue to restore normal rhythm—can improve the valve leakage. They will also build and test a model to predict which patients are most likely to benefit. The goal is to help doctors make better treatment decisions for this common heart condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
catheter ablation
What this could lead to
If successful, this could help doctors predict which patients with atrial fibrillation and mitral regurgitation will benefit most from catheter ablation, enabling more personalized treatment decisions.
What could go wrong
This is an observational study, not a treatment trial. The predictive model may not be accurate enough for widespread use, and individual results can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AF ABLATION PATIENTS WITH MODERATE+ FMR AND PERSISTENT AF are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shantou Central Hospital

    Shantou, China

  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.